Amikacin Inhalation Solution (BAY41-6551)
13084
Phase 3 small_molecule completed
Quick answer
Amikacin Inhalation Solution (BAY41-6551) for Pneumonia, Bacterial is a Phase 3 program (small_molecule) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Pneumonia, Bacterial
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed